| #45 |
Manaswini Sivaramakrishnan |
Hoffmann-La Roche |
1 |
| #45 |
Philipp Schmid |
C4 Therapeutics |
1 |
| #45 |
Silke Annika Koehler |
Basf Se |
1 |
| #45 |
Dieter Heusken |
Arrowhead Pharmaceuticals |
1 |
| #45 |
Matthias Willmann |
Novartis Ag |
1 |
| #45 |
Therese Cronin |
University of Pennsylvania |
1 |
| #45 |
Michael Quirmbach |
Novartis Ag |
1 |
| #45 |
Juergen REINHARDT |
Novartis Ag |
1 |
| #45 |
Osele Ciampi |
Hoffmann-La Roche |
1 |
| #45 |
Werner Breitenstein |
Novartis Ag |
1 |
| #45 |
Patricia Hoyle |
Evolva Sa |
1 |
| #45 |
Simon Christoph HONOLD |
Alstom Technology |
1 |
| #45 |
Johannes Tschumi |
Dsm Ip Assets B.V. |
1 |
| #45 |
Thomas Pietzonka |
Children'S Medical Center |
1 |
| #45 |
Corinna Mauth |
Straumann Holding Ag |
1 |
| #45 |
Neil Anthony Pegg |
F. Hoffmann-La Roche Ag |
1 |
| #45 |
Malte Peters |
Novartis Ag |
1 |
| #45 |
Frank Stowasser |
Novartis Ag |
1 |
| #45 |
Andreas Weichselberger |
Novartis Ag |
1 |
| #45 |
Neil Cammish |
Novartis Ag |
1 |
| #45 |
Marco Mazzotti |
Casale Sa |
1 |
| #45 |
Attilio Bondanza |
Ospedale San Raffaele S.R.L. |
1 |
| #45 |
Christoph Patsch |
Hoffmann-La Roche |
1 |
| #45 |
Tomoya Matsumoto |
Idemitsu Kosan Co. |
1 |
| #45 |
Ross Sinclair Strang |
Novartis Ag |
1 |
| #45 |
Daniel Zimmermann |
Array Biopharma |
1 |
| #45 |
Roberta Leah |
Hoffmann-La Roche |
1 |
| #45 |
Voichita Mihali |
Advansix Resins & Chemicals |
1 |
| #45 |
Thomas Bart |
— |
1 |
| #45 |
Rolf Fluri |
Siemens Aktiengesellschaft |
1 |
| #45 |
Bryan James Ulmer |
Syngenta Participations Ag |
1 |
| #45 |
Riccardo MANCUSO |
— |
1 |
| #45 |
Adrian Willem Meesen |
Dsm Ip Assets B.V. |
1 |
| #45 |
Rene Emmenegger |
Paion Uk Limited |
1 |
| #45 |
Lukas Giger |
Depuy Synthes Products |
1 |
| #45 |
Anita Dreyer |
Hoffmann-La Roche |
1 |
| #45 |
Paulo Fernandes Gomes Dos Santos |
Novartis Ag |
1 |
| #45 |
Klemens Hoegenauer |
Novartis Ag |
1 |
| #45 |
Romain Wolf |
Novartis Ag |
1 |
| #45 |
Lada Georgieva |
Caltech |
1 |
| #45 |
Pablo Oliver Velarde Pena |
Dsm Ip Assets B.V. |
1 |
| #45 |
Alexander Von Weymarn-Schärli |
— |
1 |
| #45 |
Darryl Brynley Jones |
Novartis Ag |
1 |
| #45 |
Rainer Voegeli |
Asta Pharma Aktiengesellschaft |
1 |
| #45 |
Franco E. Di Padova |
Novartis Ag |
1 |
| #45 |
Zorica DRAGIC |
Novartis Ag |
1 |
| #45 |
Irmgard Immig |
Dsm Ip Assets B.V. |
1 |
| #45 |
Felipe José Oliveira Varum |
Tillotts Pharma Ag |
1 |
| #45 |
Werner Heinz Pachinger |
Novartis Ag |
1 |
| #45 |
Madlaina Breuleux |
Basilea Pharmaceutica Ag |
1 |